Global Offshore Oil and Gas Seismic Equipment and Acquisitions Market 2020-2024
SKU ID :TNV-15139189 | Published Date: 22-Jan-2020 | No. of pages: 100Description
TOC
01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Preface
2.3 Currency conversion rates for US$
3. 03: MARKET LANDSCAPE
4. Market ecosystem
5. Market characteristics
6. Market segmentation analysis
7. Value chain analysis
04: MARKET SIZING
8. Market definition
9. Market sizing 2019
10. Market size and forecast 2019-2024
11. Market outlook
05: FIVE FORCES ANALYSIS
12. Bargaining power of buyers
13. Bargaining power of suppliers
14. Threat of new entrants
15. Threat of substitutes
16. Threat of rivalry
17. Market condition
06: MARKET SEGMENTATION BY END-USER
18. Market segmentation by end-user
19. Comparison by end-user
20. Pharmaceutical companies - Market size and forecast 2019-2024
21. Other organizations - Market size and forecast 2019-2024
22. Market opportunity by end-user
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
23. Geographic segmentation
24. Geographic comparison
25. North America - Market size and forecast 2019-2024
26. Europe - Market size and forecast 2019-2024
27. Asia - Market size and forecast 2019-2024
28. ROW - Market size and forecast 2019-2024
29. Key leading countries
30. Market opportunity
09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
31. Market drivers
32. Market challenges
11: MARKET TRENDS
33. Advent of AI in clinical research
34. Increasing outsourcing activities to CROs
35. Increasing adoption of cloud technologies in pharmaceutical production
36. and testing
12: VENDOR LANDSCAPE
37. Overview
38. Landscape disruption
39. Competitive scenario
13: VENDOR ANALYSIS
40. Vendors covered
41. Vendor classification
42. Market positioning of vendors
43. Bilcare Ltd.
44. Caligor Coghlan Pharma Services
45. Corden Pharma International GmbH
46. Mawdsley-Brooks & Co. Ltd.
47. PCI Pharma Services
48. Piramal Enterprises Ltd.
49. Sentry BioPharma Services
50. Sharp
51. The WestRock group
52. Thermo Fisher Scientific Inc.
14: APPENDIX
53. Research methodology
54. List of abbreviations
55. Definition of market positioning of vendors
15: EXPLORE TECHNAVIO
Exhibit 01: Vendors: Key offerings
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: End-user - Market share 2019-2024 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Pharmaceutical companies - Year-over-year growth 2020-2024 (%)
Exhibit 22: Other organizations - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Other organizations - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by end-user
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Bilcare Ltd. - Vendor overview
Exhibit 49: Bilcare Ltd. - Business segments
Exhibit 50: Bilcare Ltd. - Key offerings
Exhibit 51: Bilcare Ltd. - Key customers
Exhibit 52: Caligor Coghlan Pharma Services - Vendor overview
Exhibit 53: Caligor Coghlan Pharma Services - Business segments
Exhibit 54: Caligor Coghlan Pharma Services - Organizational developments
Exhibit 55: Caligor Coghlan Pharma Services - Key offerings
Exhibit 56: Caligor Coghlan Pharma Services - Key customers
Exhibit 57: Corden Pharma International GmbH - Vendor overview
Exhibit 58: Corden Pharma International GmbH - Business segments
Exhibit 59: Corden Pharma International GmbH - Organizational developments
Exhibit 60: Corden Pharma International GmbH - Key offerings
Exhibit 61: Corden Pharma International GmbH - Key customers
Exhibit 62: Mawdsley-Brooks & Co. Ltd. - Vendor overview
Exhibit 63: Mawdsley-Brooks & Co. Ltd. - Business segments
Exhibit 64: Mawdsley-Brooks & Co. Ltd. - Organizational developments
Exhibit 65: Mawdsley-Brooks & Co. Ltd. - Key offerings
Exhibit 66: Mawdsley-Brooks & Co. Ltd. - Key customers
Exhibit 67: PCI Pharma Services - Vendor overview
Exhibit 68: PCI Pharma Services - Business segments
Exhibit 69: PCI Pharma Services - Organizational developments
Exhibit 70: PCI Pharma Services - Key offerings
Exhibit 71: PCI Pharma Services - Key customers
Exhibit 72: Piramal Enterprises Ltd. - Vendor overview
Exhibit 73: Piramal Enterprises Ltd. - Business segments
Exhibit 74: Piramal Enterprises Ltd. - Organizational developments
Exhibit 75: Piramal Enterprises Ltd. - Segment focus
Exhibit 76: Piramal Enterprises Ltd. - Key offerings
Exhibit 77: Piramal Enterprises Ltd. - Key customers
Exhibit 78: Sentry BioPharma Services - Vendor overview
Exhibit 79: Sentry BioPharma Services - Business segments
Exhibit 80: Sentry BioPharma Services - Key offerings
Exhibit 81: Sentry BioPharma Services - Key customers
Exhibit 82: Sharp - Vendor overview
Exhibit 83: Sharp - Business segments
Exhibit 84: Sharp - Organizational developments
Exhibit 85: Sharp - Geographic focus
Exhibit 86: Sharp - Key offerings
Exhibit 87: Sharp - Key customers
Exhibit 88: The WestRock group - Vendor overview
Exhibit 89: The WestRock group - Business segments
Exhibit 90: The WestRock group - Organizational developments
Exhibit 91: The WestRock group - Segment focus
Exhibit 92: The WestRock group - Key offerings
Exhibit 93: The WestRock group - Key customers
Exhibit 94: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 95: Thermo Fisher Scientific Inc. - Business segments
Exhibit 96: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 97: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 98: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 99: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 100: Thermo Fisher Scientific Inc. - Key customers
Exhibit 101: Validation techniques employed for market sizing
Exhibit 102: Definition of market positioning of vendors
Tables & Figures
Companies
Arabian Geophysical and Surveying Co.
Fugro NV
ION Geophysical Corp.
Mitcham Industries Inc.
PGS ASA
Polarcus Ltd.
SAExploration Holdings Inc.
SeaBird Exploration Plc
Shearwater GeoServices Holdings AS
TGS-NOPEC Geophysical Co. ASA
- PRICE
-
$2500$4000